APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomedical CRO

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biomedical CRO Market Outlook and Growth Opportunities 2026

1 January 2026192 pages

Choose your research edition.

Industry ResearchBiomedical CRO Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomedical CRO Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biomedical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomedical CRO Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomedical CRO Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Biomedical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biomedical CRO market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biomedical CRO market include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biomedical CRO market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomedical CRO and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomedical CRO revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomedical CRO market.

Biomedical CRO Segment by Company

Charles River

Wuxi AppTec

Labcorp

Eurofins Scientific

PPD

ICON Plc

Pharmaron

Inotiv

ChemPartner

JOINN Lab

EVOTEC

Medicilon

Crown Bioscience

Champion Oncology

Biomedical CRO Segment by Type

Preclinical CRO

Clinical CRO

Biomedical CRO Segment by Application

Biological Industry

Medical Industry

Biomedical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomedical CRO status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomedical CRO key companies, revenue, market share, and recent developments.

3. To split the Biomedical CRO breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomedical CRO market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomedical CRO significant trends, drivers, influence factors in global and regions.

6. To analyze Biomedical CRO competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical CRO industry.

Chapter 3: Detailed analysis of Biomedical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomedical CRO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomedical CRO in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomedical CRO Industry Trends Table 2. Biomedical CRO Industry Drivers Table 3. Biomedical CRO Industry Opportunities and Challenges Table 4. Biomedical CRO Industry Restraints Table 5. Global Biomedical CRO Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomedical CRO Revenue Share by Company (2021-2026) Table 7. Global Biomedical CRO Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomedical CRO Key Company Manufacturing Base & Headquarters Table 9. Global Biomedical CRO Company, Product Type & Application Table 10. Global Biomedical CRO Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomedical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Preclinical CRO Table 15. Significant Companies of Clinical CRO Table 16. Global Biomedical CRO Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biomedical CRO Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biomedical CRO Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biomedical CRO Sales Value Share by Type (2021-2026) Table 20. Global Biomedical CRO Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biological Industry Table 22. Significant Companies of Medical Industry Table 23. Global Biomedical CRO Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Biomedical CRO Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Biomedical CRO Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Biomedical CRO Sales Value Share by Application (2021-2026) Table 27. Global Biomedical CRO Sales Value Share by Application (2027-2032) Table 28. Global Biomedical CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biomedical CRO Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Biomedical CRO Sales Value Share by Region (2021-2026) Table 31. Global Biomedical CRO Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Biomedical CRO Sales Value Share by Region (2027-2032) Table 33. Global Biomedical CRO Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biomedical CRO Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Biomedical CRO Sales Value Market Share by Country (2021-2026) Table 36. Global Biomedical CRO Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Biomedical CRO Sales Value Market Share by Country (2027-2032) Table 38. Charles River Company Information Table 39. Charles River Business Overview Table 40. Charles River Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Charles River Biomedical CRO Product Portfolio Table 42. Charles River Recent Development Table 43. Wuxi AppTec Company Information Table 44. Wuxi AppTec Business Overview Table 45. Wuxi AppTec Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Wuxi AppTec Biomedical CRO Product Portfolio Table 47. Wuxi AppTec Recent Development Table 48. Labcorp Company Information Table 49. Labcorp Business Overview Table 50. Labcorp Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Labcorp Biomedical CRO Product Portfolio Table 52. Labcorp Recent Development Table 53. Eurofins Scientific Company Information Table 54. Eurofins Scientific Business Overview Table 55. Eurofins Scientific Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Eurofins Scientific Biomedical CRO Product Portfolio Table 57. Eurofins Scientific Recent Development Table 58. PPD Company Information Table 59. PPD Business Overview Table 60. PPD Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. PPD Biomedical CRO Product Portfolio Table 62. PPD Recent Development Table 63. ICON Plc Company Information Table 64. ICON Plc Business Overview Table 65. ICON Plc Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ICON Plc Biomedical CRO Product Portfolio Table 67. ICON Plc Recent Development Table 68. Pharmaron Company Information Table 69. Pharmaron Business Overview Table 70. Pharmaron Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pharmaron Biomedical CRO Product Portfolio Table 72. Pharmaron Recent Development Table 73. Inotiv Company Information Table 74. Inotiv Business Overview Table 75. Inotiv Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Inotiv Biomedical CRO Product Portfolio Table 77. Inotiv Recent Development Table 78. ChemPartner Company Information Table 79. ChemPartner Business Overview Table 80. ChemPartner Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. ChemPartner Biomedical CRO Product Portfolio Table 82. ChemPartner Recent Development Table 83. JOINN Lab Company Information Table 84. JOINN Lab Business Overview Table 85. JOINN Lab Biomedical CRO Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. JOINN Lab Biomedical CRO Product Portfolio Table 87. JOINN Lab Recent Development Table 88. EVOTEC Company Information Table 89. EVOTEC Business Overview Table 90. EVOTEC Biomedical CRO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. EVOTEC Biomedical CRO Product Portfolio Table 92. EVOTEC Recent Development Table 93. Medicilon Company Information Table 94. Medicilon Business Overview Table 95. Medicilon Biomedical CRO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Medicilon Biomedical CRO Product Portfolio Table 97. Medicilon Recent Development Table 98. Crown Bioscience Company Information Table 99. Crown Bioscience Business Overview Table 100. Crown Bioscience Biomedical CRO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Crown Bioscience Biomedical CRO Product Portfolio Table 102. Crown Bioscience Recent Development Table 103. Champion Oncology Company Information Table 104. Champion Oncology Business Overview Table 105. Champion Oncology Biomedical CRO Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Champion Oncology Biomedical CRO Product Portfolio Table 107. Champion Oncology Recent Development Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Biomedical CRO Product Image Figure 2. Global Biomedical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomedical CRO Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Preclinical CRO Image Figure 8. Clinical CRO Image Figure 9. Global Biomedical CRO Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biomedical CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biomedical CRO Sales Value Share by Type (2021-2032) Figure 12. Biological Industry Image Figure 13. Medical Industry Image Figure 14. Global Biomedical CRO Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biomedical CRO Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biomedical CRO Sales Value Share by Application (2021-2032) Figure 17. Global Biomedical CRO Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Biomedical CRO Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Biomedical CRO Sales Value (2021-2032) & (US$ Million) Figure 20. North America Biomedical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Biomedical CRO Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Biomedical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Biomedical CRO Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Biomedical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Biomedical CRO Sales Value (2021-2032) & (US$ Million) Figure 26. South America Biomedical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Biomedical CRO Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Biomedical CRO Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Biomedical CRO Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Biomedical CRO Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Biomedical CRO Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical CRO
Applications
  • Biological Industry
  • Medical Industry
Companies covered
  • Charles River
  • Wuxi AppTec
  • Labcorp
  • Eurofins Scientific
  • PPD
  • ICON Plc
  • Pharmaron
  • Inotiv
  • ChemPartner
  • JOINN Lab
  • EVOTEC
  • Medicilon
  • Crown Bioscience
  • Champion Oncology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomedical CRO Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomedical CRO Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomedical CRO Market Dynamics
  1. 2.1 Biomedical CRO Industry Trends
  2. 2.2 Biomedical CRO Industry Drivers
  3. 2.3 Biomedical CRO Industry Opportunities and Challenges
  4. 2.4 Biomedical CRO Industry Restraints
3 Biomedical CRO Market by Company
  1. 3.1 Global Biomedical CRO Company Revenue Ranking in 2025
  2. 3.2 Global Biomedical CRO Revenue by Company (2021-2026)
  3. 3.3 Global Biomedical CRO Company Ranking (2024-2026)
  4. 3.4 Global Biomedical CRO Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomedical CRO Company Product Type and Application
  6. 3.6 Global Biomedical CRO Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomedical CRO Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomedical CRO Market by Type
  1. 4.1 Biomedical CRO Type Introduction
  2. 4.1.1 Preclinical CRO
  3. 4.1.2 Clinical CRO
  4. 4.2 Global Biomedical CRO Sales Value by Type
  5. 4.2.1 Global Biomedical CRO Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biomedical CRO Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biomedical CRO Sales Value Share by Type (2021-2032)
5 Biomedical CRO Market by Application
  1. 5.1 Biomedical CRO Application Introduction
  2. 5.1.1 Biological Industry
  3. 5.1.2 Medical Industry
  4. 5.2 Global Biomedical CRO Sales Value by Application
  5. 5.2.1 Global Biomedical CRO Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biomedical CRO Sales Value by Application (2021-2032)
  7. 5.2.3 Global Biomedical CRO Sales Value Share by Application (2021-2032)
6 Biomedical CRO Regional Value Analysis
  1. 6.1 Global Biomedical CRO Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomedical CRO Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomedical CRO Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomedical CRO Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomedical CRO Sales Value (2021-2032)
  7. 6.3.2 North America Biomedical CRO Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomedical CRO Sales Value (2021-2032)
  10. 6.4.2 Europe Biomedical CRO Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomedical CRO Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomedical CRO Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomedical CRO Sales Value (2021-2032)
  16. 6.6.2 South America Biomedical CRO Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomedical CRO Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomedical CRO Sales Value Share by Country, 2025 VS 2032
7 Biomedical CRO Country-level Value Analysis
  1. 7.1 Global Biomedical CRO Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomedical CRO Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomedical CRO Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomedical CRO Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomedical CRO Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomedical CRO Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomedical CRO Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomedical CRO Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomedical CRO Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomedical CRO Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomedical CRO Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomedical CRO Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomedical CRO Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomedical CRO Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomedical CRO Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomedical CRO Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomedical CRO Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomedical CRO Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomedical CRO Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomedical CRO Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomedical CRO Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomedical CRO Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomedical CRO Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomedical CRO Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomedical CRO Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomedical CRO Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomedical CRO Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomedical CRO Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomedical CRO Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomedical CRO Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomedical CRO Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomedical CRO Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomedical CRO Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomedical CRO Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomedical CRO Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Biomedical CRO Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Biomedical CRO Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Wuxi AppTec
  8. 8.2.1 Wuxi AppTec Company Information
  9. 8.2.2 Wuxi AppTec Business Overview
  10. 8.2.3 Wuxi AppTec Biomedical CRO Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
  12. 8.2.5 Wuxi AppTec Recent Developments
  13. 8.3 Labcorp
  14. 8.3.1 Labcorp Company Information
  15. 8.3.2 Labcorp Business Overview
  16. 8.3.3 Labcorp Biomedical CRO Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Labcorp Biomedical CRO Product Portfolio
  18. 8.3.5 Labcorp Recent Developments
  19. 8.4 Eurofins Scientific
  20. 8.4.1 Eurofins Scientific Company Information
  21. 8.4.2 Eurofins Scientific Business Overview
  22. 8.4.3 Eurofins Scientific Biomedical CRO Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
  24. 8.4.5 Eurofins Scientific Recent Developments
  25. 8.5 PPD
  26. 8.5.1 PPD Company Information
  27. 8.5.2 PPD Business Overview
  28. 8.5.3 PPD Biomedical CRO Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PPD Biomedical CRO Product Portfolio
  30. 8.5.5 PPD Recent Developments
  31. 8.6 ICON Plc
  32. 8.6.1 ICON Plc Company Information
  33. 8.6.2 ICON Plc Business Overview
  34. 8.6.3 ICON Plc Biomedical CRO Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ICON Plc Biomedical CRO Product Portfolio
  36. 8.6.5 ICON Plc Recent Developments
  37. 8.7 Pharmaron
  38. 8.7.1 Pharmaron Company Information
  39. 8.7.2 Pharmaron Business Overview
  40. 8.7.3 Pharmaron Biomedical CRO Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaron Biomedical CRO Product Portfolio
  42. 8.7.5 Pharmaron Recent Developments
  43. 8.8 Inotiv
  44. 8.8.1 Inotiv Company Information
  45. 8.8.2 Inotiv Business Overview
  46. 8.8.3 Inotiv Biomedical CRO Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Inotiv Biomedical CRO Product Portfolio
  48. 8.8.5 Inotiv Recent Developments
  49. 8.9 ChemPartner
  50. 8.9.1 ChemPartner Company Information
  51. 8.9.2 ChemPartner Business Overview
  52. 8.9.3 ChemPartner Biomedical CRO Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ChemPartner Biomedical CRO Product Portfolio
  54. 8.9.5 ChemPartner Recent Developments
  55. 8.10 JOINN Lab
  56. 8.10.1 JOINN Lab Company Information
  57. 8.10.2 JOINN Lab Business Overview
  58. 8.10.3 JOINN Lab Biomedical CRO Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JOINN Lab Biomedical CRO Product Portfolio
  60. 8.10.5 JOINN Lab Recent Developments
  61. 8.11 EVOTEC
  62. 8.11.1 EVOTEC Company Information
  63. 8.11.2 EVOTEC Business Overview
  64. 8.11.3 EVOTEC Biomedical CRO Revenue and Gross Margin (2021-2026)
  65. 8.11.4 EVOTEC Biomedical CRO Product Portfolio
  66. 8.11.5 EVOTEC Recent Developments
  67. 8.12 Medicilon
  68. 8.12.1 Medicilon Company Information
  69. 8.12.2 Medicilon Business Overview
  70. 8.12.3 Medicilon Biomedical CRO Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Medicilon Biomedical CRO Product Portfolio
  72. 8.12.5 Medicilon Recent Developments
  73. 8.13 Crown Bioscience
  74. 8.13.1 Crown Bioscience Company Information
  75. 8.13.2 Crown Bioscience Business Overview
  76. 8.13.3 Crown Bioscience Biomedical CRO Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Crown Bioscience Biomedical CRO Product Portfolio
  78. 8.13.5 Crown Bioscience Recent Developments
  79. 8.14 Champion Oncology
  80. 8.14.1 Champion Oncology Company Information
  81. 8.14.2 Champion Oncology Business Overview
  82. 8.14.3 Champion Oncology Biomedical CRO Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Champion Oncology Biomedical CRO Product Portfolio
  84. 8.14.5 Champion Oncology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst